198 related articles for article (PubMed ID: 38807594)
1. The role of E2F2 in cancer progression and its value as a therapeutic target.
Gao Y; Qiao X; Liu Z; Zhang W
Front Immunol; 2024; 15():1397303. PubMed ID: 38807594
[TBL] [Abstract][Full Text] [Related]
2. The E2F transcription factor 2: What do we know?
Li L; Wang S; Zhang Y; Pan J
Biosci Trends; 2021 May; 15(2):83-92. PubMed ID: 33952804
[TBL] [Abstract][Full Text] [Related]
3. [Advancement of E2F1 in Common Tumors].
Shen C; Li J; Chang S; Che G
Zhongguo Fei Ai Za Zhi; 2020 Oct; 23(10):921-926. PubMed ID: 33070516
[TBL] [Abstract][Full Text] [Related]
4. Low E2F2 activity is associated with high genomic instability and PARPi resistance.
Rennhack JP; Andrechek ER
Sci Rep; 2020 Oct; 10(1):17948. PubMed ID: 33087787
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic reader BRD4 inhibition as a therapeutic strategy to suppress E2F2-cell cycle regulation circuit in liver cancer.
Hong SH; Eun JW; Choi SK; Shen Q; Choi WS; Han JW; Nam SW; You JS
Oncotarget; 2016 May; 7(22):32628-40. PubMed ID: 27081696
[TBL] [Abstract][Full Text] [Related]
6. The transcription factor FLI1 promotes cancer progression by affecting cell cycle regulation.
Miao B; Bauer AS; Hufnagel K; Wu Y; Trajkovic-Arsic M; Pirona AC; Giese N; Taipale J; Siveke JT; Hoheisel JD; Lueong S
Int J Cancer; 2020 Jul; 147(1):189-201. PubMed ID: 31846072
[TBL] [Abstract][Full Text] [Related]
7. miR-155 regulates the proliferation and invasion of clear cell renal cell carcinoma cells by targeting E2F2.
Gao Y; Ma X; Yao Y; Li H; Fan Y; Zhang Y; Zhao C; Wang L; Ma M; Lei Z; Zhang X
Oncotarget; 2016 Apr; 7(15):20324-37. PubMed ID: 26967247
[TBL] [Abstract][Full Text] [Related]
8. E2F2 drives glioma progression via PI3K/AKT in a PFKFB4-dependent manner.
Zhang L; Liu Z; Dong Y; Kong L
Life Sci; 2021 Jul; 276():119412. PubMed ID: 33774025
[TBL] [Abstract][Full Text] [Related]
9. miR-99a reveals two novel oncogenic proteins E2F2 and EMR2 and represses stemness in lung cancer.
Feliciano A; Garcia-Mayea Y; Jubierre L; Mir C; Hummel M; Castellvi J; Hernández-Losa J; Paciucci R; Sansano I; Sun Y; Ramón Y Cajal S; Kondon H; Soriano A; Segura M; Lyakhovich A; LLeonart ME
Cell Death Dis; 2017 Oct; 8(10):e3141. PubMed ID: 29072692
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA circE2F2 promotes malignant progression of ovarian cancer cells by upregulating the expression of E2F2 protein via binding to HuR protein.
Zhang M; Xu Y; Zhang Y; Li B; Lou G
Cell Signal; 2021 Aug; 84():110014. PubMed ID: 33894314
[TBL] [Abstract][Full Text] [Related]
11. miR-155 regulates the proliferation and cell cycle of colorectal carcinoma cells by targeting E2F2.
Li T; Yang J; Lv X; Liu K; Gao C; Xing Y; Xi T
Biotechnol Lett; 2014 Sep; 36(9):1743-52. PubMed ID: 24793496
[TBL] [Abstract][Full Text] [Related]
12. Tumor-suppressive microRNA-let-7a inhibits cell proliferation via targeting of E2F2 in osteosarcoma cells.
Iwasaki T; Tanaka K; Kawano M; Itonaga I; Tsumura H
Int J Oncol; 2015 Apr; 46(4):1543-50. PubMed ID: 25647078
[TBL] [Abstract][Full Text] [Related]
13. Increased metastasis with loss of E2F2 in Myc-driven tumors.
Yuwanita I; Barnes D; Monterey MD; O'Reilly S; Andrechek ER
Oncotarget; 2015 Nov; 6(35):38210-24. PubMed ID: 26474282
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA circPVT1 Promotes Proliferation and Invasion Through Sponging miR-125b and Activating E2F2 Signaling in Non-Small Cell Lung Cancer.
Li X; Zhang Z; Jiang H; Li Q; Wang R; Pan H; Niu Y; Liu F; Gu H; Fan X; Gao J
Cell Physiol Biochem; 2018; 51(5):2324-2340. PubMed ID: 30537738
[TBL] [Abstract][Full Text] [Related]
15. Liver × receptor ligands disrupt breast cancer cell proliferation through an E2F-mediated mechanism.
Nguyen-Vu T; Vedin LL; Liu K; Jonsson P; Lin JZ; Candelaria NR; Candelaria LP; Addanki S; Williams C; Gustafsson JÅ; Steffensen KR; Lin CY
Breast Cancer Res; 2013 Jun; 15(3):R51. PubMed ID: 23809258
[TBL] [Abstract][Full Text] [Related]
16. miR-638 represses the stem cell characteristics of breast cancer cells by targeting E2F2.
Lin QY; Wang JQ; Wu LL; Zheng WE; Chen PR
Breast Cancer; 2020 Jan; 27(1):147-158. PubMed ID: 31410735
[TBL] [Abstract][Full Text] [Related]
17. LncRNA NNT-AS1 regulates the progression of lung cancer through the NNT-AS1/miR-3666/E2F2 axis.
Huang JW; Luo XY; Li ZH; Lang BP
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):238-248. PubMed ID: 31957837
[TBL] [Abstract][Full Text] [Related]
18. E2F2 inhibition induces autophagy via the PI3K/Akt/mTOR pathway in gastric cancer.
Li H; Zhao S; Shen L; Wang P; Liu S; Ma Y; Liang Z; Wang G; Lv J; Qiu W
Aging (Albany NY); 2021 Apr; 13(10):13626-13643. PubMed ID: 34091441
[TBL] [Abstract][Full Text] [Related]
19. LncRNA RCAT1 promotes tumor progression and metastasis via miR-214-5p/E2F2 axis in renal cell carcinoma.
Guo R; Zou B; Liang Y; Bian J; Xu J; Zhou Q; Zhang C; Chen T; Yang M; Wang H; Pei F; Xu Z
Cell Death Dis; 2021 Jul; 12(7):689. PubMed ID: 34244473
[TBL] [Abstract][Full Text] [Related]
20. Increased E2F2 predicts poor prognosis in patients with HCC based on TCGA data.
Zeng Z; Cao Z; Tang Y
BMC Cancer; 2020 Oct; 20(1):1037. PubMed ID: 33115417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
